Biospecimen Procurement for Immuno-Oncology Research

This study aims to collect and store biological samples (like blood and tumor tissue) from people with cancer or pre-cancerous conditions. Researchers want to understand why different cancers respond differently to treatments, especially immunotherapy (treatments that use your body's immune system to fight cancer). By studying these samples, they hope to develop more effective treatments. You can join if you are at least 18 years old and have a diagnosis of cancer, a pre-cancerous condition, or an immune system problem that increases your risk of cancer. The main goal is to acquire these samples for ongoing research.

Study design
This is an observational study, meaning no experimental treatments are given. Up to 500 participants will be enrolled.
What's involved
You would provide samples such as blood, tumor tissue, and other body fluids. Your diagnosis will be confirmed by the NCI Laboratory of Pathology.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT02682667

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

Recruiting
Not specifiedAges 18+Observational
National Cancer Institute (NCI)
~500 participants
Updated 2026-08-27 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Sample Acquisition
Measured over Ongoing
Multiple Myeloma
Lymphoma, Non-Hodgkin
Leukemia-Lymphoma, Adult T-Cell
Hodgkin Disease
Non-Small Cell Lung Cancer
1 sites across 1 states
Maryland1
  • Scott M Norberg, D.O. · PRINCIPAL_INVESTIGATOR · National Cancer Institute (NCI)

Opens a ready-to-send draft in your own email app — review before sending.

  • Sample AcquisitionOngoing

    Biospecimen collection for study and understanding of disease.